Yahoo! Finance: Biotechnology Industry News: Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder Jun 6th 2013, 01:00 [PR Newswire] - WASHINGTON, June 5, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions